- Home
- VRCA vs SCNX Comparison
VRCA vs SCNX Comparison
Compare VRCA & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRCA
- SCNX
- Stock Information
- Founded
- VRCA 2013
- SCNX 2010
- Country
- VRCA United States
- SCNX United States
- Employees
- VRCA N/A
- SCNX N/A
- Industry
- VRCA Biotechnology: Pharmaceutical Preparations
- SCNX Other Pharmaceuticals
- Sector
- VRCA Health Care
- SCNX Health Care
- Exchange
- VRCA Nasdaq
- SCNX Nasdaq
- Market Cap
- VRCA 32.7M
- SCNX 31.5M
- IPO Year
- VRCA 2018
- SCNX 2020
- Fundamental
- Price
- VRCA $3.77
- SCNX $0.73
- Analyst Decision
- VRCA Hold
- SCNX
- Analyst Count
- VRCA 2
- SCNX 0
- Target Price
- VRCA N/A
- SCNX N/A
- AVG Volume (30 Days)
- VRCA 247.5K
- SCNX 64.8M
- Earning Date
- VRCA 11-06-2025
- SCNX 11-12-2025
- Dividend Yield
- VRCA N/A
- SCNX N/A
- EPS Growth
- VRCA N/A
- SCNX N/A
- EPS
- VRCA N/A
- SCNX N/A
- Revenue
- VRCA $14,704,000.00
- SCNX $128,202.00
- Revenue This Year
- VRCA $332.45
- SCNX N/A
- Revenue Next Year
- VRCA $12.85
- SCNX N/A
- P/E Ratio
- VRCA N/A
- SCNX N/A
- Revenue Growth
- VRCA 5.72
- SCNX N/A
- 52 Week Low
- VRCA $3.28
- SCNX $0.46
- 52 Week High
- VRCA $13.60
- SCNX $8.72
- Technical
- Relative Strength Index (RSI)
- VRCA 44.18
- SCNX 46.97
- Support Level
- VRCA $3.37
- SCNX $0.67
- Resistance Level
- VRCA $3.99
- SCNX $1.11
- Average True Range (ATR)
- VRCA 0.25
- SCNX 0.31
- MACD
- VRCA 0.03
- SCNX -0.02
- Stochastic Oscillator
- VRCA 45.12
- SCNX 4.66
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.